Vistin Pharma ASA Working Capital to Net Assets Ratio
Vistin Pharma ASA working capital to net assets ratio. Vistin Pharma ASA (VISTN) has a Working Capital to Net Assets ratio of 41.1% as of March 2026. Working capital of Nkr144.02 Million (current assets of Nkr217.54 Million minus current liabilities of Nkr73.52 Million) is measured against net assets of Nkr350.31 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Vistin Pharma ASA (2016–2025)
Working capital to net assets ratio of Vistin Pharma ASA from 2016 to 2025. This chart shows how Vistin Pharma ASA's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 41.1%, reflecting working capital of Nkr144.02 Million against net assets of Nkr350.31 Million NOK. See VISTN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Vistin Pharma ASA Working Capital to Net Assets Ratio by Year (2016–2025)
Vistin Pharma ASA working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Vistin Pharma ASA from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Vistin Pharma ASA's balance sheet.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 35.5% | Nkr116.80 Million | Nkr328.81 Million | Nkr203.52 Million | Nkr86.72 Million | ▲ +9.9 pp |
| 2024 | 25.6% | Nkr79.22 Million | Nkr309.53 Million | Nkr143.19 Million | Nkr63.97 Million | ▼ -5.2 pp |
| 2023 | 30.8% | Nkr99.30 Million | Nkr322.77 Million | Nkr168.77 Million | Nkr69.47 Million | ▲ +15.2 pp |
| 2022 | 15.5% | Nkr42.44 Million | Nkr273.26 Million | Nkr154.11 Million | Nkr111.67 Million | ▼ -19.6 pp |
| 2021 | 35.1% | Nkr96.80 Million | Nkr275.89 Million | Nkr137.83 Million | Nkr41.03 Million | ▼ -5.0 pp |
| 2020 | 40.1% | Nkr109.32 Million | Nkr272.40 Million | Nkr141.53 Million | Nkr32.20 Million | ▼ -37.6 pp |
| 2019 | 77.7% | Nkr321.39 Million | Nkr413.40 Million | Nkr394.63 Million | Nkr73.24 Million | ▲ +4.7 pp |
| 2018 | 73.1% | Nkr254.96 Million | Nkr348.85 Million | Nkr389.29 Million | Nkr134.33 Million | ▲ +20.5 pp |
| 2017 | 52.6% | Nkr63.21 Million | Nkr120.16 Million | Nkr160.06 Million | Nkr96.85 Million | ▼ -25.3 pp |
| 2016 | 77.9% | Nkr145.35 Million | Nkr186.61 Million | Nkr225.97 Million | Nkr80.62 Million | — |